rdf:type |
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018802,
umls-concept:C0030705,
umls-concept:C0040732,
umls-concept:C0205088,
umls-concept:C0205390,
umls-concept:C0220825,
umls-concept:C0439859,
umls-concept:C0522523,
umls-concept:C1135922,
umls-concept:C1274040
|
pubmed:issue |
7
|
pubmed:dateCreated |
2011-1-21
|
pubmed:abstractText |
The SEISMIC study was an open-label, prospective, randomised study to assess the safety and feasibility of percutaneous myoblast implantation in heart failure patients with implanted cardioverter-defibrillators (ICD).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1969-6213
|
pubmed:author |
pubmed-author:BartunekJozefJ,
pubmed-author:DuckersHenricus JHJ,
pubmed-author:GershlickAnthonyA,
pubmed-author:HehrleinChristophC,
pubmed-author:HoutgraafJacoJ,
pubmed-author:LegrandVictorV,
pubmed-author:MacayaCarlosC,
pubmed-author:NienaberChristophC,
pubmed-author:PetersNicholasN,
pubmed-author:SchoferJoachimJ,
pubmed-author:SerruysPatrick WPW,
pubmed-author:SiminiakThomaszT,
pubmed-author:SmitsPeterP,
pubmed-author:WaltenbergerJohannesJ,
pubmed-author:van MieghemWalterW
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
805-12
|
pubmed:meshHeading |
pubmed-meshheading:21252013-Adult,
pubmed-meshheading:21252013-Aged,
pubmed-meshheading:21252013-Amiodarone,
pubmed-meshheading:21252013-Anti-Arrhythmia Agents,
pubmed-meshheading:21252013-Arrhythmias, Cardiac,
pubmed-meshheading:21252013-Cells, Cultured,
pubmed-meshheading:21252013-Disease Progression,
pubmed-meshheading:21252013-Electrocardiography, Ambulatory,
pubmed-meshheading:21252013-Exercise Tolerance,
pubmed-meshheading:21252013-Female,
pubmed-meshheading:21252013-Heart Failure,
pubmed-meshheading:21252013-Humans,
pubmed-meshheading:21252013-Injections,
pubmed-meshheading:21252013-Male,
pubmed-meshheading:21252013-Middle Aged,
pubmed-meshheading:21252013-Myoblasts, Skeletal,
pubmed-meshheading:21252013-Myocardium,
pubmed-meshheading:21252013-Stroke Volume,
pubmed-meshheading:21252013-Transplantation, Autologous,
pubmed-meshheading:21252013-Ventricular Function, Left
|
pubmed:year |
2011
|
pubmed:articleTitle |
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.
|
pubmed:affiliation |
Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands. h.duckers@erasmusmc.nl
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|